ReviewThe Korean journal of internal medicine2023

Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease.

Yaerim Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.